Avantor, Inc. (AVTR) is a Technology stock trading at $15.44 (as of 2026-09-15), with a market capitalization of $10.44B. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Avantor distributes lab consumables (reagents, chemicals, tips, columns) and custom bioscience products to pharma, academic, and government labs worldwide, earning revenue through product markups and fulfillment. Roughly three-quarters of sales are recurring distribution of standard items; the smaller custom-bioproducts arm adds differentiation but is far less profitable.
Profit is the narrow spread between bulk-purchase cost of chemicals and supplies and the per-order fulfillment fee charged to tens of thousands of labs; structurally it is a labor-intensive, low-margin warehousing and logistics business wearing a science brand.
| VWR Distribution | $1.1B |
| Bioscience & Medtech | $0.4B |
Business quality (Weak): Flat revenue, 6% operating margin, and negative ROE signal a value-destroying distribution model that has not yet found a path to durable above-9% returns on capital.
| Price | $15.44 |
| Market Cap | $10.44B |
| EV / EBITDA | 117.9 |
| Price / Book | 1.85 |
| Price / Sales | 1.59 |
| FCF Yield | 4.4% |
| DCF Value (model) | $13.31 |
| DCF Upside vs Price | -13.8% |
| Revenue (TTM) | $6.55B |
| Net Margin | -8.1% |
| Return on Equity | -10.3% |
| Debt / Equity | 0.66 |
| Current Ratio | 1.78 |
| Revenue Growth (YoY) | 0.5% |
| EPS Growth (YoY) | -33.3% |
| FCF Growth (YoY) | 12.7% |
| Altman Z-Score | 1.81 (grey) |
| Piotroski F-Score | 4/9 (moderate) |
| Sector P/E (Technology) | 30.8 |
| Industry P/E (Measuring & Control Equipment) | 43.9 |
| Top Institutional Holder | Dodge & Cox ($1.19B) |
| Institutional Holders Tracked | 10 |
| Congressional Trades (recent) | 9 |
| Sector | Technology |
| Industry | Measuring & Control Equipment |
| CEO | Emmanuel Ligner |
| Employees | 13,500 |
| Country | US |
| IPO Date | 2019-05-17 |
Data as of 2026-09-15.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.